Cellebrite DI Ltd. (CLBT) Institutional Holdings & 13F Data (Q2 2026)

CLBT ranks #2963 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CLBT is a top-conviction position for Axon Enterprise, Inc. — at 100.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CLBT belongs to True Wind Capital Management, L.P., but the position matters far more to Axon Enterprise, Inc., who has 100.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

CLBT is down 3.1% today, but institutions show net buying of $151.0M this quarter — a divergence between today's price move and the underlying institutional flow.

CLBT closed its latest fiscal year with net income of $78.3M, and currently trades at a P/E of 35.2.

• Profitable — net income of $78.3M in the latest fiscal year
• Revenue grew 18.6% year over year
• Net income improved year over year, from -$283.0M to $78.3M
• Generated $173.5M in positive operating cash flow
• Current ratio of 1.56x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.94x equity — within a conventional range